Literature DB >> 465866

The effect of intracerebroventricular administration of methionine-enkephalin on the stress-induced secretion of corticosterone in mice.

A Gibson, M Ginsburg, M Hall, S L Hart.   

Abstract

Ether stress or intracerebroventricular (i.c.v.) administration of saline, met-enkephalin, or naltrexone raised plasma corticosterone levels in mice. The response to ether stress was abolished by a preceding ether stress or by pretreatment with i.c.v. saline or naltrexone. However, following i.c.v. met-enkephalin, plasma corticosterone was significantly elevated by ether stress, the effect being blocked by simultaneous injection of met-enkephalin and naltrexone. Met-enkephalin appears to prevent fast-feedback inhibition of the hypothalamus-pituitary-adrenal system.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 465866      PMCID: PMC2043635          DOI: 10.1111/j.1476-5381.1979.tb13660.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

1.  Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine.

Authors:  J Hughes
Journal:  Brain Res       Date:  1975-05-02       Impact factor: 3.252

2.  Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse.

Authors:  T J HALEY; W G MCCORMICK
Journal:  Br J Pharmacol Chemother       Date:  1957-03

3.  The estimation of small amounts of corticosterone in rat plasma.

Authors:  N ZENKER; D E BERNSTEIN
Journal:  J Biol Chem       Date:  1958-04       Impact factor: 5.157

4.  The influence of corticosteroids on the secretion of corticotrophin and its hypothalamic releasing hormone.

Authors:  J C Buckingham
Journal:  J Physiol       Date:  1979-01       Impact factor: 5.182

5.  The effects of opiate receptor agonists and antagonists on the stress-induced secretion of corticosterone in mice.

Authors:  A Gibson; M Ginsburg; M Hall; S L Hart
Journal:  Br J Pharmacol       Date:  1979-01       Impact factor: 8.739

6.  A synthetic enkephalin analogue with prolonged parenteral and oral analgesic activity.

Authors:  D Roemer; H H Buescher; R C Hill; J Pless; W Bauer; F Cardinaux; A Closse; D Hauser; R Huguenin
Journal:  Nature       Date:  1977-08-11       Impact factor: 49.962

7.  The effects of some neurotransmitter substances on the production of corticotrophin releasing factor by the rat hypothalamus in vitro [proceedings].

Authors:  J C Buckingham; J R Hodges
Journal:  Br J Pharmacol       Date:  1978-06       Impact factor: 8.739

8.  Dynamic asymmetries in the corticosteroid feedback path and distribution-metabolism-binding elements of the adrenocortical system.

Authors:  M F Dallman; F E Yates
Journal:  Ann N Y Acad Sci       Date:  1969-04-21       Impact factor: 5.691

9.  Foot shock induced stress decreases leu5-enkephalin immunoreactivity in rat hypothalamus.

Authors:  J Rossier; R Guillemin; F Bloom
Journal:  Eur J Pharmacol       Date:  1978-04-15       Impact factor: 4.432

10.  Dynamics and mechanics of corticosteroid feedback at the hypothalamus and anterior pituitary gland.

Authors:  M T Jones; E W Hillhouse; J L Burden
Journal:  J Endocrinol       Date:  1977-06       Impact factor: 4.286

View more
  3 in total

1.  Leucine-enkephalin and methionine-enkephalin produce opposing effects on plasma corticosterone levels in ether-stressed mice.

Authors:  A Gibson; S L Hart; A Shabib
Journal:  Br J Pharmacol       Date:  1980-12       Impact factor: 8.739

2.  The delta opioid receptor antagonist, SoRI-9409, decreases yohimbine stress-induced reinstatement of ethanol-seeking.

Authors:  Carsten K Nielsen; Jeffrey A Simms; Jade J Bito-Onon; Rui Li; Subramaniam Ananthan; Selena E Bartlett
Journal:  Addict Biol       Date:  2011-02-11       Impact factor: 4.280

3.  Effects of adrenalectomy and hypophysectomy on enkephalin content of the rat hypothalamus.

Authors:  A Gibson; M Ginsburg; S L Hart; I Kitchen
Journal:  Br J Pharmacol       Date:  1980-12       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.